Related Experiment Videos
Radiotherapy with heavy charged particles at Lawrence Berkeley Laboratory
Journal of the Canadian Association of Radiologists
|March 1, 1980
Summary
Heavy charged particle therapy, including helium and heavier ions, shows promise for treating human cancers. Early results suggest comparable tumor control and acceptable toxicity, supporting further clinical trials.
Area of Science:
- Medical Physics
- Radiation Oncology
- Particle Therapy
Background:
- Heavy charged particles offer potential advantages in cancer treatment.
- Helium ions provide improved dose distribution, sparing normal tissues.
- Heavier ions like carbon, neon, and argon may enhance biologic effectiveness, particularly against hypoxic tumors.
Purpose of the Study:
- To evaluate the clinical utility of heavy charged particle irradiation for human cancers.
- To assess the safety and efficacy of helium, carbon, neon, and argon ions in a Phase I-II trial.
Main Methods:
- A Phase I-II clinical trial involving 157 patients irradiated with heavy charged particles since July 1975.
- Utilized particles included helium, carbon, neon, and argon ions.
- Ongoing studies include a Phase III randomized trial for pancreatic carcinoma.
Main Results:
- Initial results with helium particles are promising, leading to a Phase III trial.
- Tumor control within the irradiated area appears comparable to current megavoltage irradiation.
- Complications observed to date are acceptably low across a heterogeneous patient group.
Conclusions:
- Heavy charged particle therapy demonstrates potential for effective cancer treatment.
- Further investigation into heavy charged particles is warranted based on favorable initial outcomes.
- The observed efficacy and safety profile support continued clinical research in this field.